ClearPoint Neuro (CLPT) Receivables - Net (2011 - 2026)

ClearPoint Neuro has disclosed Receivables - Net across 16 years of filings, most recently posting $8.7 million for Q1 2026.

• Receivables - Net for Q1 2026 came in at $8.7 million, up 137.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.7 million (up 137.25% YoY), and the FY2025 annual result was $6.5 million, up 38.96% from the prior year.
• Receivables - Net came in at $8.7 million for Q1 2026 at ClearPoint Neuro, up from $6.5 million in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $8.7 million in Q1 2026 to a low of $2.2 million in Q1 2022.
• The 5-year median for Receivables - Net is $3.4 million (2022), against an average of $3.8 million.
• Across the five-year window, Receivables - Net surged 16640.0% in 2022 and fell 28.94% in 2023, its largest moves.
• ClearPoint Neuro's Receivables - Net stood at $2.7 million in 2022, then advanced by 20.49% to $3.2 million in 2023, then soared by 46.78% to $4.7 million in 2024, then surged by 38.96% to $6.5 million in 2025, then jumped by 32.26% to $8.7 million in 2026.
• The last three Receivables - Net figures came in at $8.7 million (Q1 2026), $6.5 million (Q4 2025), and $4.0 million (Q3 2025), per Business Quant data.